AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
AstraZeneca has released findings from two Phase III studies of Ultomiris (ravulizumab) in thrombotic microangiopathy following haematopoietic stem…
AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
AstraZeneca has released findings from two Phase III studies of Ultomiris (ravulizumab) in thrombotic microangiopathy following haematopoietic stem…
UK Stocks Drop as AstraZeneca’s Heart Drug Trial Results, Geopolitical Tensions Weigh
MT Newswires -Shutterstock London’s FTSE 100 closed 0.16% lower on Thursday, driven by a decline in heavyweight AstraZeneca…